Crescent Biopharma Stock (NASDAQ:CBIO)
Previous Close
$14.25
52W Range
$10.83 - $63.00
50D Avg
$13.83
200D Avg
$23.02
Market Cap
$196.58M
Avg Vol (3M)
$101.84K
Beta
-
Div Yield
-
CBIO Company Profile
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.